Oncotelic Therapeutics, Inc. (OTLC) has 20 known insider and institutional holders on record. The largest holder is Trieu Vuong with 93,025,782 shares. Other notable holders include Symphony Capital Partners LP and Park Chulho.
OTLC Insider Ownership
Top Holder
Trieu Vuong
93,025,782 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Trieu Vuong |
10 Percent Owner, Officer: Chairman and CEO |
93,025,782 |
2025-01-31 |
|
| 2 |
Symphony Capital Partners Lp |
10 Percent Owner |
27,117,118 |
2009-08-12 |
|
| 3 |
Park Chulho |
Chief Technology Officer |
2,833,992 |
2020-11-23 |
|
| 4 |
Saund Saran |
Chief Business Officer |
675,000 |
2021-09-08 |
|
| 5 |
Soderberg Per Olof |
Director |
650,000 |
2006-12-18 |
|
| 6 |
Maida Anthony E Iii |
Chief Clin. Ops. Officer |
600,000 |
2021-09-08 |
|
| 7 |
King Steven W |
Director |
500,000 |
2021-09-08 |
|
| 8 |
Schwieterman William D |
President and CEO |
500,000 |
2018-06-22 |
|
| 9 |
Diamond David |
Director |
451,467 |
2021-07-16 |
|
| 10 |
Chin Richard |
President and CEO |
392,074 |
2008-01-15 |
|
| 11 |
Laffer Arthur B |
Director |
374,232 |
2010-01-05 |
|
| 12 |
Shah Amit B. |
Chief Financial Officer |
358,837 |
2021-07-16 |
|
| 13 |
Citron Joel Tomas |
Director |
311,077 |
2006-11-22 |
|
| 14 |
Sandage Bobby W. Jr., Phd. |
Director |
258,171 |
2018-06-22 |
|
| 15 |
Reynolds Donald Rogers |
Director |
258,171 |
2018-06-22 |
|
| 16 |
Pedder Simon |
Director |
258,171 |
2018-06-22 |
|
| 17 |
Chaplin David |
Director |
258,171 |
2018-06-22 |
|
| 18 |
Kollins John A |
Chief Executive Officer |
250,000 |
2009-01-22 |
|
| 19 |
Loar Matthew M |
Chief Financial Officer |
250,000 |
2018-06-22 |
|
| 20 |
Shiebler William N |
Director |
236,002 |
2011-01-04 |
|
No ownership data available for OTLC.
